Phase II trial of ponatinib in patients with chronic myeloid leukemia resistant to one previous tyrosine kinase inhibitor

David Sanford, Hagop Kantarjtan, Jeffrey Skinner, Elias Jabbour, Jorge Cortes

Research output: Contribution to journalLetter

12 Scopus citations
Original languageEnglish (US)
Pages (from-to)e494-e495
JournalHaematologica
Volume100
Issue number12
DOIs
StatePublished - Jan 1 2015
Externally publishedYes

Keywords

  • Chronic myeloid leukemia
  • Phase II
  • Ponatinib
  • Resistant
  • Tyrosine kinase inhibitor

ASJC Scopus subject areas

  • Hematology

Cite this